Keyphrases
Skeletal muscle
100%
Insulin Signaling
100%
Diabetic Mice
100%
Autophagic Signaling
100%
Acylated Ghrelin
100%
Diabetic
36%
Impaired Insulin Secretion
27%
Antidiabetic Action
18%
Phosphorylation
9%
Insulin
9%
Insulin Receptor Substrate 1 (IRS1)
9%
Type 2 Diabetes Mellitus (T2DM)
9%
Control Sensitivity
9%
Akt Phosphorylation
9%
Glycemic Control
9%
Blood Glucose
9%
Glucose Transporter 4 (GLUT4)
9%
2-phase
9%
Protein Kinase B/Akt
9%
Mammalian Target of Rapamycin (mTOR)
9%
Phase II Clinical Trial
9%
Insulin Sensitivity
9%
PDH Activity
9%
Glucose Tolerance
9%
Hyperphagia
9%
Prader-Willi Syndrome
9%
Phase Ib Clinical Trial
9%
Biochemistry, Genetics and Molecular Biology
Ghrelin
100%
Skeletal Muscle
100%
Insulin Signaling
36%
Clinical Trial
18%
Antidiabetic Activity
18%
Protein Kinase B
18%
Prader-Willi Syndrome
9%
Insulin Sensitivity
9%
Glucose Blood Level
9%
Glycemic Control
9%
Muscle Level
9%
mTOR Signaling
9%
Insulin Receptor
9%